Cardiovascular Considerations in the Management of People With Suspected Long COVID.
Quinn, Kieran L, Lam, Grace Y, Walsh, Jillian F et al. · The Canadian journal of cardiology · 2023 · DOI
Quick Summary
This review examines how doctors should evaluate and treat heart-related symptoms in people with long COVID. It highlights that about 15% of Canadians infected with COVID-19 develop persistent symptoms lasting more than 12 weeks, including fatigue, shortness of breath, chest pain, and irregular heartbeats. The authors emphasize that doctors need to consider conditions like ME/CFS, postexertional malaise (symptom flare-ups after activity), and dysautonomia (problems with the autonomic nervous system) when evaluating these patients.
Why It Matters
This guideline is important for ME/CFS patients because it recognizes the significant overlap between long COVID and ME/CFS, and explicitly directs clinicians to consider postexertional malaise when evaluating cardiac symptoms. By integrating patient perspectives and acknowledging dysautonomia and activity-related symptom exacerbation, it may help prevent harmful interventions and improve diagnostic accuracy for patients with these complex conditions.
Observed Findings
Approximately 15% of Canadian adults with SARS-CoV-2 infection develop long COVID symptoms persisting beyond 12 weeks.
Common cardiovascular symptoms in long COVID include fatigue, shortness of breath, chest pain, and palpitations.
Clinicians must consider ME/CFS, postexertional malaise, dysautonomia (including inappropriate sinus tachycardia and POTS), and mast cell activation syndrome as differential diagnoses.
Cardiovascular symptoms in long COVID often present as a constellation of findings that are challenging to diagnose and treat.
Inferred Conclusions
Cardiologists and generalists need practical guidance that integrates recognition of ME/CFS and postexertional malaise when evaluating long COVID patients with cardiac symptoms.
A multidisciplinary approach incorporating both clinical expertise and patient lived experience is essential for appropriate management of long COVID cardiovascular complications.
Standard cardiac workup may be insufficient without considering dysautonomic and post-exertional mechanisms underlying symptom presentation.
Remaining Questions
What are the optimal diagnostic criteria and testing strategies to distinguish between primary cardiac pathology, dysautonomia, and postexertional malaise in long COVID patients?
What specific treatment approaches are most effective for long COVID patients with different cardiovascular manifestation profiles?
What This Study Does Not Prove
This guideline does not establish the prevalence, pathophysiology, or optimal treatment for specific cardiac complications of long COVID—it synthesizes existing evidence rather than presenting new research data. It also does not determine whether cardiac symptoms in long COVID are primarily organic (structural/physiological) or related to dysautonomia and postexertional malaise, nor does it provide definitive proof that specific diagnostic tests distinguish long COVID from ME/CFS or other conditions.